Literature DB >> 11983658

The bispectral index response to tracheal intubation is similar in normotensive and hypertensive patients.

Masayasu Nakayama1, Hiromichi Ichinose, Shuji Yamamoto, Noriaki Kanaya, Akiyoshi Namiki.   

Abstract

PURPOSE: To compare the hemodynamic and bispectral index (BIS) responses to tracheal intubation in normotensive and hypertensive patients.
METHOD: Three minutes after induction of anesthesia with thiamylal and fentanyl, tracheal intubation was performed in 24 normotensive and 22 hypertensive patients. Heart rate (HR), mean arterial pressure (MAP), and BIS were measured every minute.
RESULTS: Tracheal intubation increased HR, MAP, and BIS in both normotensive and hypertensive patients. The increase in MAP was significantly greater in hypertensive patients than in normotensive patients, but there were no differences in HR or BIS in the two groups of patients.
CONCLUSION: Patients with and without hypertension exhibit the same arousal response (as measured by BIS) to tracheal intubation despite the enhanced vasopressor response in hypertensive patients.

Entities:  

Mesh:

Year:  2002        PMID: 11983658     DOI: 10.1007/BF03017920

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  3 in total

1.  Clevidipine controls intraoperative blood pressure in an adolescent with renal failure.

Authors:  Joseph D Tobias; Joy Allee; Venkataraman Ramachandran; Ted Groshong
Journal:  J Pediatr Pharmacol Ther       Date:  2009-07

2.  Effects of phenytoin therapy on bispectral index and haemodynamic changes following induction and tracheal intubation.

Authors:  Parmod K Bithal; Mihir P Pandia; Rajendra S Chouhan; Hemanshu Prabhakar; Girija P Rath; Hari Hara Dash; Manish K Marda
Journal:  Indian J Anaesth       Date:  2009-04

3.  Sevoflurane requirement during elective ankle day surgery: the effects of etirocoxib premedication, a prospective randomised study.

Authors:  Ibrahim Turan; Anette Hein; Eva Jacobson; Jan G Jakobsson
Journal:  J Orthop Surg Res       Date:  2008-09-11       Impact factor: 2.359

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.